Timothy Davern, MD
Gastroenterology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 14
Offices
14 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Memorial Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Davern’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G79521 · Current
Licensed to practise in California · since 1994 · expires 2028-07-31 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$121,473
Medicare paid this office $121,473 for 466 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 181 | $34,029 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $30,177 | $106 |
| Long return visit (40+ min) | 173 | $28,616 | $116 |
| Critical care, first 30-74 minutes | 12 | $9,779 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $6,749 | $150 |
See all 9 services
| Long return visit (40+ min) | 181 | $34,029 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $30,177 | $106 |
| Long return visit (40+ min) | 173 | $28,616 | $116 |
| Critical care, first 30-74 minutes | 12 | $9,779 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $6,749 | $150 |
| New patient visit (45+ min) | 20 | $2,337 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,737 | $116 |
| New patient visit (45+ min) | 14 | $1,454 | $104 |
| Measurement of liver stiffness | 26 | $757 | $29 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
466 Original Medicare patients in 2024. Average age 70 · Under 65 17% · 85 and older 4% · Women 50% · Also on Medicaid 37% · Health risk score 2.49. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Chronic kidney disease 46% · Diabetes 45% · Coronary heart disease 31% · Depression 25% · Heart failure 19% · Atrial fibrillation 17% · COPD 13% · Cancer 11% · Dementia 6% · Stroke 6%.
The office billed $512,910, Medicare allowed $162,317 and paid $121,473; for 1,017 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 466 | 1,017 | 70 | 2.49 | $512,910 | $121,473 |
| 2023 | 418 | 999 | 69 | 2.58 | $476,890 | $121,350 |
| 2022 | 432 | 943 | 69 | 2.49 | $440,829 | $110,678 |
| 2021 | 409 | 983 | 69 | 2.66 | $441,200 | $112,522 |
| 2020 | 427 | 966 | 68 | 2.70 | $487,542 | $102,262 |
| 2019 | 438 | 1,040 | 68 | 2.74 | $496,731 | $106,408 |
| 2018 | 444 | 1,169 | 67 | 2.75 | $546,279 | $113,445 |
| 2017 | 393 | 792 | 67 | 2.61 | $351,761 | $71,162 |
| 2016 | 421 | 912 | 65 | 2.82 | $396,623 | $81,053 |
| 2015 | 426 | 979 | 65 | 2.68 | $458,903 | $97,064 |
| 2014 | 376 | 937 | 65 | 2.63 | $476,458 | $104,492 |
| 2013 | 396 | 1,006 | 63 | 2.79 | $576,581 | $120,841 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 198 | $38,936 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $30,817 | $108 |
| Long return visit (40+ min) | 154 | $26,472 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,176 | $158 |
| Critical care, first 30-74 minutes | 11 | $5,400 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,942 | $118 |
| New patient visit (45+ min) | 22 | $2,568 | $117 |
| New patient visit (45+ min) | 13 | $1,617 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,220 | $72 |
| Measurement of liver stiffness | 23 | $591 | $26 |
2022: 8 services
| Long return visit (40+ min) | 193 | $39,042 | $122 |
| Long return visit (40+ min) | 155 | $26,673 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $20,475 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,283 | $178 |
| New patient visit (45+ min) | 33 | $3,844 | $116 |
| New patient visit (45+ min) | 31 | $3,306 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,915 | $121 |
| Measurement of liver stiffness | 11 | $314 | $29 |
2021: 11 services
| Long return visit (40+ min) | 206 | $40,486 | $123 |
| Long return visit (40+ min) | 139 | $27,401 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $21,084 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,208 | $183 |
| New patient visit (45+ min) | 30 | $3,751 | $125 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,065 | $109 |
| New patient visit (45+ min) | 15 | $1,855 | $124 |
| Return visit (30+ min) | 14 | $1,364 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,055 | $66 |
| Return visit (30+ min) | 12 | $984 | $76 |
| Measurement of liver stiffness | 16 | $154 | $10 |
2020: 10 services
| Long return visit (40+ min) | 175 | $28,457 | $111 |
| Long return visit (40+ min) | 166 | $25,866 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $18,464 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,536 | $184 |
| Critical care, first 30-74 minutes | 16 | $7,158 | $199 |
| New patient visit (45+ min) | 24 | $2,559 | $107 |
| New patient visit (45+ min) | 21 | $2,502 | $119 |
| New patient visit (60+ min) | 13 | $1,991 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,203 | $67 |
| Measurement of liver stiffness | 27 | $289 | $11 |
2019: 13 services
| Long return visit (40+ min) | 199 | $31,311 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $23,615 | $94 |
| Long return visit (40+ min) | 126 | $17,716 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $9,101 | $182 |
| Critical care, first 30-74 minutes | 13 | $5,319 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $4,328 | $66 |
| New patient visit (45+ min) | 25 | $2,809 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,706 | $123 |
| New patient visit (45+ min) | 17 | $2,214 | $130 |
| Return visit (30+ min) | 15 | $1,154 | $77 |
| Measurement of liver stiffness | 27 | $679 | $25 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $530 | $35 |
| Measurement of liver stiffness | 15 | $183 | $12 |
2018: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $33,279 | $90 |
| Long return visit (40+ min) | 195 | $30,166 | $107 |
| Long return visit (40+ min) | 104 | $15,046 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,346 | $174 |
| Critical care, first 30-74 minutes | 20 | $7,690 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,325 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,464 | $117 |
| New patient visit (60+ min) | 17 | $2,210 | $130 |
| Return visit (30+ min) | 25 | $2,116 | $78 |
| New patient visit (45+ min) | 21 | $2,041 | $97 |
| New patient visit (60+ min) | 11 | $1,685 | $153 |
| Return visit (30+ min) | 15 | $1,029 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $571 | $34 |
| Measurement of liver stiffness | 11 | $314 | $29 |
| Measurement of liver stiffness | 22 | $298 | $12 |
2017: 12 services
| Long return visit (40+ min) | 149 | $20,732 | $106 |
| Long return visit (40+ min) | 110 | $14,407 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $11,579 | $90 |
| New patient visit (45+ min) | 29 | $3,566 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,509 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,259 | $63 |
| Return visit (30+ min) | 32 | $2,459 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,890 | $118 |
| New patient visit (45+ min) | 16 | $1,678 | $105 |
| Return visit (30+ min) | 24 | $1,169 | $47 |
| Measurement of liver stiffness | 52 | $654 | $12 |
| Measurement of liver stiffness | 14 | $409 | $29 |
2016: 14 services
| Long return visit (40+ min) | 134 | $18,643 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $15,702 | $91 |
| Long return visit (40+ min) | 98 | $13,320 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,689 | $178 |
| Return visit (30+ min) | 70 | $5,534 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $3,804 | $63 |
| New patient visit (45+ min) | 24 | $3,134 | $131 |
| Return visit (30+ min) | 42 | $3,010 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,197 | $116 |
| New patient visit (45+ min) | 14 | $1,594 | $114 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,344 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $653 | $34 |
| Measurement of liver stiffness | 25 | $631 | $25 |
| Measurement of liver stiffness | 54 | $614 | $11 |
2015: 13 services
| Long return visit (40+ min) | 167 | $24,450 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $21,240 | $93 |
| Long return visit (40+ min) | 85 | $10,847 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $5,947 | $65 |
| Return visit (30+ min) | 68 | $5,851 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,772 | $180 |
| New patient visit (60+ min) | 29 | $4,536 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,558 | $122 |
| New patient visit (45+ min) | 17 | $1,959 | $115 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,852 | $97 |
| New patient visit (45+ min) | 15 | $1,841 | $123 |
| Return visit (30+ min) | 25 | $1,764 | $68 |
| Measurement of liver stiffness | 34 | $442 | $13 |
2014: 9 services
| Long return visit (40+ min) | 235 | $43,355 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $27,475 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,588 | $181 |
| New patient visit (60+ min) | 42 | $7,416 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,023 | $64 |
| Long return visit (40+ min) | 25 | $2,714 | $88 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,591 | $113 |
| Return visit (30+ min) | 22 | $2,343 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,589 | $122 |
2013: 10 services
| Long return visit (40+ min) | 254 | $48,934 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $24,138 | $90 |
| Critical care, first 30-74 minutes | 20 | $16,827 | $191 |
| New patient visit (60+ min) | 30 | $4,908 | $164 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,049 | $176 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,579 | $119 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $3,235 | $116 |
| New patient visit (45+ min) | 16 | $2,164 | $135 |
| Return visit (30+ min) | 24 | $2,010 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,061 | $62 |
Medicaid work
$18,826 in 2024
Medicaid paid $18,826 for 388 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 223 | $12,068 |
| Long return visit (40+ min) | 165 | $6,757 |
| 2024 | 388 | 2 | 25 | $18,826 |
| 2023 | 408 | 2 | 35 | $17,235 |
| 2022 | 269 | 2 | 25 | $14,229 |
| 2021 | 365 | 2 | 27 | $22,563 |
| 2020 | 346 | 2 | 38 | $13,409 |
| 2019 | 147 | 2 | 18 | $6,366 |
| 2018 | 196 | 2 | 22 | $9,335 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 225 | $10,557 |
| Long return visit (40+ min) | 183 | $6,678 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 129 | $7,297 |
| Long return visit (40+ min) | 140 | $6,932 |
2021
| Long return visit (40+ min) | 218 | $13,075 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 147 | $9,488 |
2020
| Long return visit (40+ min) | 229 | $8,855 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $4,554 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 94 | $3,958 |
| Long return visit (40+ min) | 53 | $2,408 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 90 | $4,699 |
| Long return visit (40+ min) | 106 | $4,636 |
Drugs they prescribed that Part D paid
$1,408,188
Pharmacies billed $1,408,188 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (30 of 1,994) in 2024. A higher opioid share than 9 in 10 peers; the typical gastroenterology clinician is at 0%.
1,499 generic and fewer than 11 brand-name prescriptions · $1,408,188 in drug cost · 247 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 186 | $665,197 | $3,576 |
| Vemlidy | 165 | $260,512 | $1,579 |
| Ursodiol | 205 | $29,638 | $145 |
| Entecavir | 78 | $21,264 | $273 |
| Tacrolimus | 189 | $20,672 | $109 |
See all 31 drugs
| Xifaxan | 186 | $665,197 | $3,576 |
| Vemlidy | 165 | $260,512 | $1,579 |
| Ursodiol | 205 | $29,638 | $145 |
| Entecavir | 78 | $21,264 | $273 |
| Tacrolimus | 189 | $20,672 | $109 |
| Mycophenolate Mofetil | 120 | $13,463 | $112 |
| Lokelma | 13 | $10,406 | $800 |
| Tenofovir Disoproxil | 43 | $6,980 | $162 |
| Lactulose | 72 | $6,825 | $95 |
| Mycophenolic Acid | 22 | $3,402 | $155 |
| Budesonide Ec | 11 | $3,228 | $293 |
| Sucralfate | 12 | $2,392 | $199 |
| Azathioprine | 64 | $2,203 | $34 |
| Pantoprazole | 115 | $1,278 | $11 |
| Eplerenone | 23 | $1,261 | $55 |
| Constulose | 26 | $963 | $37 |
| Ondansetron | 16 | $698 | $44 |
| Spironolactone | 96 | $644 | $7 |
| Propranolol | 14 | $441 | $31 |
| Furosemide | 102 | $404 | $4 |
| Hydrocodone-Acetaminophen | 20 | $305 | $15 |
| Fludrocortisone Acetate | 18 | $277 | $15 |
| Prednisone | 31 | $235 | $8 |
| Potassium Chloride | 27 | $233 | $9 |
| Sodium Chloride | 12 | $231 | $19 |
| Omeprazole | 23 | $206 | $9 |
| Gabapentin | 14 | $121 | $9 |
| Sulfamethoxazole-Trimethoprim | 18 | $83 | $5 |
| Amlodipine Besylate | 17 | $72 | $4 |
| Ciprofloxacin | 15 | $60 | $4 |
| Trazodone | 12 | $39 | $3 |
Year by year
| 2024 | 1,994 | 250 | 2% (30) | None | $1,408,188 |
| 2023 | 2,183 | 241 | 1% (20) | 23% | $1,504,894 |
| 2022 | 1,919 | 240 | None | None | $1,420,999 |
| 2021 | 2,059 | 241 | 1% (19) | None | $1,595,376 |
| 2020 | 1,834 | 225 | 1% (25) | None | $1,647,886 |
| 2019 | 1,702 | 212 | 1% (24) | None | $1,465,858 |
| 2018 | 1,881 | 215 | 2% (43) | None | $1,498,465 |
| 2017 | 1,872 | 218 | 2% (43) | 27% | $2,297,630 |
| 2016 | 2,121 | 222 | 3% (52) | None | $3,699,538 |
| 2015 | 2,473 | 252 | 2% (59) | 32% | $7,629,137 |
| 2014 | 2,314 | 230 | 2% (42) | 37% | $9,104,538 |
| 2013 | 1,924 | 199 | 5% (96) | 32% | $736,558 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Xifaxan | 182 | $660,499 | $3,629 |
| Epclusa | 12 | $325,000 | $27,083 |
| Vemlidy | 143 | $234,539 | $1,640 |
| Ursodiol | 238 | $39,564 | $166 |
| Tacrolimus | 210 | $34,725 | $165 |
| Valganciclovir | 30 | $18,364 | $612 |
| Entecavir | 76 | $16,145 | $212 |
| Budesonide Ec | 28 | $15,220 | $544 |
| Lactulose | 78 | $9,292 | $119 |
| Mycophenolate Mofetil | 111 | $8,912 | $80 |
| Tenofovir Disoproxil | 34 | $7,969 | $234 |
| Everolimus | 12 | $7,301 | $608 |
| Azathioprine | 52 | $5,223 | $100 |
| Sucralfate | 16 | $4,703 | $294 |
| Mycophenolic Acid | 18 | $4,345 | $241 |
| Pantoprazole | 140 | $2,182 | $16 |
| Eplerenone | 19 | $1,271 | $67 |
| Spironolactone | 82 | $1,160 | $14 |
| Fluconazole | 30 | $837 | $28 |
| Constulose | 16 | $824 | $52 |
| Potassium Chloride | 40 | $630 | $16 |
| Furosemide | 101 | $625 | $6 |
| Prednisone | 39 | $598 | $15 |
| Fludrocortisone Acetate | 24 | $568 | $24 |
| Amlodipine Besylate | 31 | $502 | $16 |
| Sodium Chloride | 19 | $473 | $25 |
| Omeprazole | 14 | $404 | $29 |
| Gabapentin | 22 | $389 | $18 |
| Tamsulosin | 11 | $273 | $25 |
| Sulfamethoxazole-Trimethoprim | 34 | $256 | $8 |
| Ciprofloxacin | 38 | $231 | $6 |
| Ondansetron | 23 | $190 | $8 |
| Hydrocodone-Acetaminophen | 11 | $149 | $14 |
| Metronidazole | 19 | $120 | $6 |
2022: 27 drugs
| Xifaxan | 187 | $584,646 | $3,126 |
| Epclusa | 11 | $291,721 | $26,520 |
| Vemlidy | 136 | $207,501 | $1,526 |
| Ursodiol | 218 | $43,604 | $200 |
| Tacrolimus | 183 | $32,585 | $178 |
| Entecavir | 83 | $31,777 | $383 |
| Mycophenolate Mofetil | 88 | $9,656 | $110 |
| Mycophenolic Acid | 27 | $8,331 | $309 |
| Valganciclovir | 13 | $7,835 | $603 |
| Lactulose | 59 | $6,849 | $116 |
| Budesonide Ec | 11 | $6,776 | $616 |
| Azathioprine | 55 | $6,664 | $121 |
| Pantoprazole | 121 | $2,396 | $20 |
| Tenofovir Disoproxil | 42 | $2,105 | $50 |
| Vancomycin | 11 | $2,051 | $186 |
| Spironolactone | 128 | $1,758 | $14 |
| Constulose | 13 | $984 | $76 |
| Eplerenone | 12 | $797 | $66 |
| Potassium Chloride | 46 | $726 | $16 |
| Fluconazole | 12 | $544 | $45 |
| Furosemide | 82 | $503 | $6 |
| Prednisone | 37 | $462 | $12 |
| Fludrocortisone Acetate | 22 | $438 | $20 |
| Ciprofloxacin | 33 | $168 | $5 |
| Amlodipine Besylate | 29 | $140 | $5 |
| Famotidine | 11 | $100 | $9 |
| Sulfamethoxazole-Trimethoprim | 17 | $39 | $2 |
2021: 36 drugs
| Xifaxan | 188 | $606,970 | $3,229 |
| Epclusa | 17 | $449,616 | $26,448 |
| Vemlidy | 174 | $237,887 | $1,367 |
| Ursodiol | 173 | $37,606 | $217 |
| Tacrolimus | 203 | $33,725 | $166 |
| Entecavir | 72 | $32,238 | $448 |
| Valganciclovir | 24 | $20,101 | $838 |
| Mycophenolic Acid | 26 | $11,228 | $432 |
| Veltassa | 11 | $11,149 | $1,014 |
| Eplerenone | 15 | $6,735 | $449 |
| Mycophenolate Mofetil | 84 | $6,295 | $75 |
| Lactulose | 53 | $4,275 | $81 |
| Budesonide Ec | 11 | $3,030 | $275 |
| Azathioprine | 53 | $2,129 | $40 |
| Prevalite | 16 | $2,032 | $127 |
| Midodrine | 12 | $1,951 | $163 |
| Pantoprazole | 110 | $1,829 | $17 |
| Tenofovir Disoproxil | 13 | $1,231 | $95 |
| Spironolactone | 92 | $986 | $11 |
| Fluconazole | 31 | $844 | $27 |
| Generlac | 12 | $782 | $65 |
| Constulose | 18 | $782 | $43 |
| Prednisone | 72 | $717 | $10 |
| Gabapentin | 21 | $493 | $23 |
| Omeprazole | 19 | $455 | $24 |
| Furosemide | 77 | $409 | $5 |
| Ondansetron | 20 | $281 | $14 |
| Potassium Chloride | 22 | $247 | $11 |
| Propranolol | 12 | $210 | $17 |
| Amlodipine Besylate | 24 | $192 | $8 |
| Hydrocodone-Acetaminophen | 17 | $188 | $11 |
| Ciprofloxacin | 53 | $183 | $3 |
| Sulfamethoxazole-Trimethoprim | 21 | $154 | $7 |
| Metoprolol | 20 | $151 | $8 |
| Metronidazole | 15 | $74 | $5 |
| Lorazepam | 11 | $12 | $1 |
2020: 31 drugs
| Xifaxan | 154 | $493,286 | $3,203 |
| Epclusa | 16 | $414,539 | $25,909 |
| Vemlidy | 122 | $164,169 | $1,346 |
| Ursodiol | 155 | $46,114 | $298 |
| Tacrolimus | 195 | $38,868 | $199 |
| Entecavir | 99 | $20,592 | $208 |
| Mycophenolic Acid | 27 | $15,158 | $561 |
| Mycophenolate Mofetil | 107 | $10,130 | $95 |
| Valganciclovir | 19 | $7,271 | $383 |
| Eplerenone | 15 | $3,896 | $260 |
| Tenofovir Disoproxil | 20 | $3,420 | $171 |
| Budesonide Ec | 20 | $2,873 | $144 |
| Lactulose | 51 | $2,105 | $41 |
| Pantoprazole | 116 | $1,735 | $15 |
| Fluconazole | 21 | $1,276 | $61 |
| Azathioprine | 35 | $1,216 | $35 |
| Midodrine | 11 | $1,208 | $110 |
| Spironolactone | 65 | $912 | $14 |
| Constulose | 16 | $900 | $56 |
| Generlac | 16 | $830 | $52 |
| Prednisone | 65 | $517 | $8 |
| Omeprazole | 20 | $415 | $21 |
| Fludrocortisone Acetate | 21 | $405 | $19 |
| Ondansetron | 26 | $367 | $14 |
| Furosemide | 52 | $328 | $6 |
| Ciprofloxacin | 49 | $311 | $6 |
| Potassium Chloride | 12 | $165 | $14 |
| Hydrocodone-Acetaminophen | 17 | $135 | $8 |
| Metronidazole | 21 | $116 | $6 |
| Sulfamethoxazole-Trimethoprim | 18 | $58 | $3 |
| Amlodipine Besylate | 13 | $47 | $4 |
2019: 32 drugs
| Xifaxan | 164 | $434,393 | $2,649 |
| Harvoni | 12 | $383,965 | $31,997 |
| Trientine | 11 | $214,926 | $19,539 |
| Vemlidy | 57 | $81,199 | $1,425 |
| Ursodiol | 144 | $57,426 | $399 |
| Entecavir | 105 | $45,523 | $434 |
| Tacrolimus | 174 | $29,788 | $171 |
| Mycophenolic Acid | 23 | $12,021 | $523 |
| Tenofovir Disoproxil | 61 | $8,448 | $138 |
| Mycophenolate Mofetil | 88 | $8,265 | $94 |
| Carafate | 12 | $6,048 | $504 |
| Lactulose | 51 | $2,739 | $54 |
| Pantoprazole | 130 | $2,182 | $17 |
| Azathioprine | 26 | $1,378 | $53 |
| Constulose | 26 | $1,356 | $52 |
| Spironolactone | 48 | $966 | $20 |
| Fluconazole | 17 | $913 | $54 |
| Eplerenone | 14 | $803 | $57 |
| Prednisone | 46 | $559 | $12 |
| Generlac | 16 | $528 | $33 |
| Fludrocortisone Acetate | 18 | $512 | $28 |
| Omeprazole | 18 | $364 | $20 |
| Ondansetron | 34 | $352 | $10 |
| Furosemide | 48 | $310 | $6 |
| Potassium Chloride | 17 | $293 | $17 |
| Ciprofloxacin | 31 | $231 | $7 |
| Amlodipine Besylate | 27 | $131 | $5 |
| Hydrocodone-Acetaminophen | 14 | $121 | $9 |
| Sulfamethoxazole-Trimethoprim | 22 | $118 | $5 |
| Metronidazole | 19 | $115 | $6 |
| Trazodone | 14 | $106 | $8 |
| Ranitidine | 11 | $54 | $5 |
2018: 34 drugs
| Xifaxan | 148 | $364,465 | $2,463 |
| Ursodiol | 147 | $58,441 | $398 |
| Entecavir | 85 | $52,761 | $621 |
| Tenofovir Disoproxil | 62 | $35,115 | $566 |
| Vemlidy | 14 | $34,406 | $2,458 |
| Voriconazole | 20 | $23,572 | $1,179 |
| Tacrolimus | 155 | $23,128 | $149 |
| Valganciclovir | 34 | $20,959 | $616 |
| Mycophenolic Acid | 33 | $15,883 | $481 |
| Sirolimus | 13 | $11,562 | $889 |
| Mycophenolate Mofetil | 101 | $6,001 | $59 |
| Lactulose | 67 | $2,669 | $40 |
| Azathioprine | 51 | $1,839 | $36 |
| Pantoprazole | 105 | $1,381 | $13 |
| Fludrocortisone Acetate | 44 | $914 | $21 |
| Spironolactone | 50 | $764 | $15 |
| Generlac | 17 | $739 | $43 |
| Prednisone | 53 | $626 | $12 |
| Constulose | 14 | $558 | $40 |
| Warfarin | 20 | $428 | $21 |
| Potassium Chloride | 11 | $412 | $37 |
| Omeprazole | 30 | $372 | $12 |
| Fluconazole | 11 | $367 | $33 |
| Furosemide | 68 | $320 | $5 |
| Levothyroxine | 13 | $315 | $24 |
| Ondansetron | 33 | $315 | $10 |
| Metoprolol | 38 | $312 | $8 |
| Ciprofloxacin | 48 | $277 | $6 |
| Hydrocodone-Acetaminophen | 17 | $173 | $10 |
| Amlodipine Besylate | 25 | $142 | $6 |
| Trazodone | 13 | $98 | $8 |
| Tramadol | 13 | $96 | $7 |
| Metronidazole | 11 | $87 | $8 |
| Sulfamethoxazole-Trimethoprim | 13 | $36 | $3 |
2017: 38 drugs
| Harvoni | 22 | $693,859 | $31,539 |
| Xifaxan | 153 | $316,812 | $2,071 |
| Sovaldi | 12 | $293,130 | $24,428 |
| Viread | 78 | $85,080 | $1,091 |
| Entecavir | 90 | $75,266 | $836 |
| Ursodiol | 117 | $38,521 | $329 |
| Tacrolimus | 210 | $37,336 | $178 |
| Valganciclovir | 13 | $32,283 | $2,483 |
| Vemlidy | 13 | $26,853 | $2,066 |
| Mycophenolic Acid | 29 | $19,043 | $657 |
| Cellcept | 15 | $12,028 | $802 |
| Truvada | 12 | $9,132 | $761 |
| Mycophenolate Mofetil | 85 | $8,138 | $96 |
| Nexium | 11 | $3,338 | $303 |
| Azathioprine | 29 | $2,090 | $72 |
| Lactulose | 61 | $1,573 | $26 |
| Spironolactone | 70 | $1,382 | $20 |
| Nadolol | 14 | $1,287 | $92 |
| Pantoprazole | 94 | $1,082 | $12 |
| Generlac | 28 | $890 | $32 |
| Fludrocortisone Acetate | 32 | $762 | $24 |
| Omeprazole | 44 | $682 | $16 |
| Rabeprazole | 12 | $621 | $52 |
| Prednisone | 38 | $559 | $15 |
| Calcitriol | 17 | $546 | $32 |
| Constulose | 14 | $543 | $39 |
| Potassium Chloride | 17 | $356 | $21 |
| Furosemide | 81 | $335 | $4 |
| Metoprolol | 42 | $253 | $6 |
| Propranolol | 15 | $223 | $15 |
| Ciprofloxacin | 40 | $177 | $4 |
| Amlodipine Besylate | 36 | $173 | $5 |
| Ondansetron | 19 | $166 | $9 |
| Hydrocodone-Acetaminophen | 16 | $119 | $7 |
| Metronidazole | 14 | $101 | $7 |
| Tramadol | 15 | $86 | $6 |
| Olanzapine | 16 | $84 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $28 | $2 |
2016: 38 drugs
| Harvoni | 48 | $1,488,281 | $31,006 |
| Sovaldi | 25 | $701,319 | $28,053 |
| Daklinza | 21 | $443,500 | $21,119 |
| Xifaxan | 213 | $425,037 | $1,995 |
| Viread | 83 | $81,897 | $987 |
| Entecavir | 100 | $79,228 | $792 |
| Valganciclovir | 23 | $43,275 | $1,882 |
| Ursodiol | 128 | $37,412 | $292 |
| Tacrolimus | 208 | $28,804 | $138 |
| Cellcept | 17 | $13,077 | $769 |
| Mycophenolic Acid | 18 | $8,308 | $462 |
| Mycophenolate Mofetil | 81 | $5,773 | $71 |
| Lamivudine Hbv | 15 | $5,272 | $351 |
| Lactulose | 53 | $2,537 | $48 |
| Ribavirin | 16 | $1,880 | $117 |
| Spironolactone | 105 | $1,609 | $15 |
| Nadolol | 17 | $1,486 | $87 |
| Azathioprine | 38 | $1,385 | $36 |
| Constulose | 21 | $1,032 | $49 |
| Cholestyramine | 13 | $959 | $74 |
| Pantoprazole | 79 | $857 | $11 |
| Furosemide | 131 | $648 | $5 |
| Prednisone | 52 | $566 | $11 |
| Ciprofloxacin | 39 | $565 | $14 |
| Ondansetron | 18 | $562 | $31 |
| Calcitriol | 14 | $530 | $38 |
| Generlac | 17 | $518 | $30 |
| Fludrocortisone Acetate | 35 | $488 | $14 |
| Omeprazole | 45 | $468 | $10 |
| Amlodipine Besylate | 44 | $357 | $8 |
| Metoprolol | 37 | $314 | $8 |
| Hydrocodone-Acetaminophen | 14 | $226 | $16 |
| Tramadol | 33 | $222 | $7 |
| Olanzapine | 19 | $210 | $11 |
| Clopidogrel | 12 | $131 | $11 |
| Atorvastatin | 12 | $127 | $11 |
| Metronidazole | 11 | $78 | $7 |
| Sulfamethoxazole-Trimethoprim | 25 | $61 | $2 |
2015: 47 drugs
| Harvoni | 187 | $5,929,419 | $31,708 |
| Sovaldi | 23 | $643,158 | $27,963 |
| Xifaxan | 209 | $367,165 | $1,757 |
| Viread | 72 | $66,753 | $927 |
| Ursodiol | 149 | $51,300 | $344 |
| Entecavir | 43 | $44,517 | $1,035 |
| Valganciclovir | 17 | $43,312 | $2,548 |
| Tacrolimus | 215 | $35,708 | $166 |
| Baraclude | 23 | $24,433 | $1,062 |
| Cellcept | 17 | $22,251 | $1,309 |
| Rapamune | 13 | $21,723 | $1,671 |
| Truvada | 11 | $14,904 | $1,355 |
| Prograf | 27 | $13,522 | $501 |
| Ribavirin | 62 | $11,756 | $190 |
| Nexium | 15 | $5,317 | $354 |
| Opium Tincture | 11 | $5,008 | $455 |
| Lamivudine Hbv | 13 | $4,593 | $353 |
| Mycophenolate Mofetil | 65 | $4,231 | $65 |
| Lactulose | 85 | $3,357 | $39 |
| Pantoprazole | 113 | $1,362 | $12 |
| Cholestyramine | 11 | $1,301 | $118 |
| Kionex | 16 | $1,301 | $81 |
| Spironolactone | 78 | $1,197 | $15 |
| Azathioprine | 39 | $1,039 | $27 |
| Nadolol | 11 | $957 | $87 |
| Generlac | 32 | $855 | $27 |
| Calcitriol | 20 | $840 | $42 |
| Prednisone | 39 | $729 | $19 |
| Hydroxyzine | 17 | $716 | $42 |
| Omeprazole | 91 | $695 | $8 |
| Fludrocortisone Acetate | 32 | $540 | $17 |
| Ciprofloxacin | 51 | $445 | $9 |
| Furosemide | 99 | $412 | $4 |
| Hydrocodone-Acetaminophen | 33 | $361 | $11 |
| Metoprolol | 52 | $281 | $5 |
| Zolpidem | 17 | $224 | $13 |
| Warfarin | 14 | $220 | $16 |
| Olanzapine | 15 | $204 | $14 |
| Metronidazole | 24 | $204 | $8 |
| Potassium Chloride | 19 | $191 | $10 |
| Atorvastatin | 11 | $142 | $13 |
| Trazodone | 28 | $140 | $5 |
| Ondansetron | 15 | $139 | $9 |
| Amlodipine Besylate | 28 | $138 | $5 |
| Sulfamethoxazole-Trimethoprim | 25 | $86 | $3 |
| Tramadol | 16 | $84 | $5 |
| Alendronate | 13 | $52 | $4 |
2014: 38 drugs
| Sovaldi | 197 | $5,635,309 | $28,606 |
| Olysio | 78 | $1,763,085 | $22,604 |
| Harvoni | 30 | $964,424 | $32,147 |
| Xifaxan | 225 | $334,563 | $1,487 |
| Viread | 49 | $50,922 | $1,039 |
| Procrit | 16 | $50,732 | $3,171 |
| Baraclude | 27 | $39,157 | $1,450 |
| Ribavirin | 103 | $27,400 | $266 |
| Ursodiol | 124 | $23,924 | $193 |
| Tacrolimus | 116 | $19,741 | $170 |
| Truvada | 13 | $16,979 | $1,306 |
| Nexium | 19 | $8,368 | $440 |
| Mycophenolic Acid | 16 | $6,558 | $410 |
| Mycophenolate Mofetil | 65 | $5,596 | $86 |
| Lamivudine Hbv | 11 | $3,994 | $363 |
| Lactulose | 85 | $3,178 | $37 |
| Ribasphere | 29 | $3,146 | $108 |
| Gengraf | 11 | $1,763 | $160 |
| Spironolactone | 78 | $1,517 | $19 |
| Calcitriol | 39 | $1,368 | $35 |
| Nadolol | 21 | $1,274 | $61 |
| Omeprazole | 99 | $1,173 | $12 |
| Fludrocortisone Acetate | 47 | $1,094 | $23 |
| Generlac | 42 | $1,013 | $24 |
| Azathioprine | 46 | $1,000 | $22 |
| Pantoprazole | 74 | $828 | $11 |
| Hydrocodone-Acetaminophen | 31 | $610 | $20 |
| Prednisone | 21 | $411 | $20 |
| Furosemide | 100 | $386 | $4 |
| Metoprolol | 52 | $368 | $7 |
| Olanzapine | 14 | $360 | $26 |
| Ciprofloxacin | 49 | $341 | $7 |
| Propranolol | 12 | $159 | $13 |
| Amlodipine Besylate | 24 | $156 | $6 |
| Hydroxyzine | 12 | $109 | $9 |
| Trazodone | 21 | $98 | $5 |
| Zolpidem | 12 | $79 | $7 |
| Sulfamethoxazole-Trimethoprim | 11 | $53 | $5 |
2013: 37 drugs
| Xifaxan | 228 | $329,607 | $1,446 |
| Valcyte | 19 | $67,717 | $3,564 |
| Baraclude | 20 | $37,809 | $1,890 |
| Viread | 21 | $21,907 | $1,043 |
| Tacrolimus | 88 | $15,879 | $180 |
| Nexium | 37 | $12,165 | $329 |
| Cellcept | 11 | $8,144 | $740 |
| Mycophenolate Mofetil | 45 | $5,991 | $133 |
| Ursodiol | 93 | $5,604 | $60 |
| Epivir Hbv | 12 | $5,001 | $417 |
| Ribasphere | 13 | $4,435 | $341 |
| Dexilant | 17 | $3,778 | $222 |
| Lyrica | 13 | $2,781 | $214 |
| Lactulose | 42 | $1,844 | $44 |
| Calcitriol | 49 | $1,813 | $37 |
| Omeprazole | 91 | $1,689 | $19 |
| Azathioprine | 63 | $1,689 | $27 |
| Spironolactone | 66 | $1,245 | $19 |
| Fludrocortisone Acetate | 58 | $1,206 | $21 |
| Gengraf | 11 | $1,149 | $104 |
| Generlac | 49 | $1,009 | $21 |
| Hydrocodone-Acetaminophen | 61 | $954 | $16 |
| Nadolol | 16 | $899 | $56 |
| Pantoprazole | 67 | $745 | $11 |
| Furosemide | 96 | $501 | $5 |
| Prednisone | 44 | $435 | $10 |
| Warfarin | 23 | $360 | $16 |
| Ondansetron | 11 | $314 | $29 |
| Amlodipine Besylate | 27 | $281 | $10 |
| Metoprolol | 42 | $245 | $6 |
| Tramadol | 27 | $202 | $7 |
| Klor-Con M20 | 12 | $193 | $16 |
| Ciprofloxacin | 38 | $185 | $5 |
| Propranolol | 16 | $182 | $11 |
| Metronidazole | 17 | $175 | $10 |
| Zolpidem | 23 | $126 | $5 |
| Sulfamethoxazole-Trimethoprim | 22 | $113 | $5 |
Professional record
- NPI
- 1699723379
- Licence
- CA 27766, CA G79521California G79521: Current · expires 2028-07-31
- Trained
- Columbia University College of Physicians and Surgeons, 1990
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 0G7952100
- Taxonomy
- Federal specialty code 207RT0003X (207RT0003X); Internal medicine (207R00000X); Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-05-04
- NPI last updated
- 2020-11-16
- NPI record certified
- 2020-11-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1601 Esplanade Ste 3, Chico, CA, 95926 · 2367 Harrison Ave, Eureka, CA, 95501 · 1189 E Herndon Ave, Fresno, CA, 93720 · 1401 Spanos Ct Ste 125, Modesto, CA, 95355 · 165 Rowland Way Ste 201, Novato, CA, 94945 · 3300 Webster St Ste 202, Oakland, CA, 94609 · 795 El Camino Real, Palo Alto, CA, 94301 · 1315 Alhambra Blvd Ste 210, Sacramento, CA, 95816 · 1431 Noriega St, San Francisco, CA, 94122 · 2340 Clay St Fl 2, San Francisco, CA, 94115 · 350 Parnassus Ave, San Francisco, CA, 94143 · 899 Valencia St, San Francisco, CA, 94110 · 3880 S Bascom Ave Ste 113, San Jose, CA, 95124 · 3883 Airway Dr, Santa Rosa, CA, 95403 · 990 Sonoma Ave, Santa Rosa, CA, 95404